[Infantile encephalopathy associated with the MELAS A3243G mutation. Case report]

José Guevara-Campos1, Lucía Gonzalez-Guevara, Yulimar Parada

  • 1Servicio Pediatriá, Hospital Felipe Guevara Rojas, El Tigre, estado Anzoátegui, Venezuela. joguevara90@hotmail.com

Investigacion Clinica
|June 30, 2007
PubMed

Insights

Mitochondrial encephalopathies, like MELAS, stem from mitochondrial DNA (mtDNA) alterations. Early diagnosis in infants with specific symptoms, including lactic acidosis, is crucial for timely intervention and improved outcomes.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Mitochondrial encephalopathies are a class of diseases caused by mitochondrial DNA (mtDNA) mutations.
  • The MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) phenotype is frequently associated with the A3243G mtDNA mutation.
  • MERRF (myoclonic epilepsy with ragged red fibers) is linked to specific tRNA Lys mutations (A8344G, A8566G).

Observation:

  • A 7-month-old female infant presented with early signs of encephalopathy, including convulsions, psychomotor developmental delay, and lactic acidosis.
  • Electroencephalogram (EEG) findings were consistent with an encephalopathic process.
  • The patient was found to have the A3243G mtDNA mutation.

Findings:

  • Treatment with ACTH for one month resulted in clinical and electroencephalographic improvements.
  • Current management includes B-vitamins, L-Carnitine, and urinary alkalizing agents.
  • The A3243G mutation was identified as the likely cause of the infant's encephalopathy.

Implications:

  • Infants presenting with unexplained convulsions, developmental delay, lactic acidosis, and abnormal EEG patterns should be evaluated for mitochondrial disease.
  • Early detection of mtDNA mutations allows for targeted therapies and management strategies.
  • This case highlights the importance of mtDNA analysis in the differential diagnosis of pediatric encephalopathies.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...